Announcement by Food and Drug Administration applies to millions of Americans who are specifically vulnerable due to organ transplants, certain cancers or other disorders.
Some other countries, including France and Israel, have similar recommendations.
It’s harder for vaccines to improve the immune system that is pressed by drugs or certain diseases, so that patients don’t always get the same protection as healthy people – and small studies show at least some, additional doses can be a solution.
“This action is about ensuring our most vulnerable …
more protected from Covid-19,” Dr.
Rochelle Walensky, Director of the Center for Control and Prevention of the disease, said ahead of the FDA announcement.
Importantly, the decision is only valid for this high-risk group, around 3% of adults A.S.
This is not an opening for a booster dose for the general population.
Instead, health authorities consider the extra dose part of the initial Covid-19 vaccine recipe for compromised immunity.
For example, France since April has encouraged that such patients get a third dose of four weeks after their second law shot.
Separately, Health Officials A.S.
Continue to monitor strictly if and when the average human immunity requires quite a lot of steering for everyone, but for now, vaccines continue to offer strong protection for the general population.